5-Amino-1MQ Research: NNMT Inhibition, Metabolism, and Cellular Energy

5-Amino-1MQ, short for 5-amino-1-methylquinolinium, is a synthetic small molecule studied for its ability to inhibit nicotinamide N-methyltransferase, commonly abbreviated as NNMT.

In laboratory research, 5-Amino-1MQ is investigated in connection with cellular energy regulation, nicotinamide metabolism, NAD⁺-related pathways, methyl-donor balance, adipose-tissue biology, glucose regulation, and skeletal-muscle research.

For research purposes only. Not for human consumption. This article is educational and does not provide medical, dosing, diagnostic, weight-loss, or treatment guidance.

What Is 5-Amino-1MQ?

5-Amino-1MQ is a quinolinium-based small molecule developed as a research inhibitor of NNMT. NNMT is an enzyme that transfers a methyl group from S-adenosylmethionine, or SAM, to nicotinamide. This reaction produces 1-methylnicotinamide and S-adenosylhomocysteine.

Although 5-Amino-1MQ is often listed alongside peptides, it is not technically a peptide. Peptides are chains of amino acids connected by peptide bonds. 5-Amino-1MQ is a low-molecular-weight chemical compound without an amino-acid sequence.

• Compound type → synthetic small-molecule enzyme inhibitor
• Common abbreviation → 5-Amino-1MQ, 5A1MQ, or 5A-1MQ
• Full name → 5-amino-1-methylquinolinium
• Primary research target → nicotinamide N-methyltransferase, or NNMT
• Research focus → cellular metabolism, NAD⁺-related pathways, methylation balance, adipose biology, and muscle research

Why 5-Amino-1MQ Attracts Research Interest

5-Amino-1MQ attracts scientific interest because NNMT sits at the intersection of several important metabolic systems. NNMT uses nicotinamide, which is involved in NAD⁺ salvage, and SAM, one of the cell’s primary methyl donors.

By influencing these substrates and their downstream products, NNMT may affect cellular energy metabolism, methylation capacity, gene regulation, lipid storage, glucose handling, and tissue-specific metabolic adaptation.

Most published 5-Amino-1MQ findings are preclinical and come from enzyme assays, cultured cells, and animal models. The compound remains a laboratory research tool rather than an approved treatment or dietary supplement.

How 5-Amino-1MQ Works in Research Models

5-Amino-1MQ is studied as an inhibitor of NNMT. Under normal conditions, NNMT transfers a methyl group from SAM to nicotinamide. This forms 1-methylnicotinamide, often abbreviated as 1-MNA, and converts SAM into S-adenosylhomocysteine, or SAH.

Because nicotinamide can be recycled through the NAD⁺ salvage pathway and SAM supports methylation reactions throughout the cell, NNMT activity can influence several metabolic systems at once.

• NNMT inhibition → reduces nicotinamide methylation in experimental systems
• Nicotinamide research → evaluates how NNMT activity may influence NAD⁺-related metabolism
• Methyl-donor research → examines SAM, SAH, and cellular methylation balance
• Adipocyte research → investigates lipid storage, adipocyte size, and energy regulation
• Glucose research → studies insulin sensitivity and glucose tolerance in animal models
• Muscle research → explores myoblast differentiation and muscle stem-cell activity

5-Amino-1MQ is not a direct source of NAD⁺ and should not be described as a stimulant, mitochondrial fuel, or receptor agonist. Its primary research action is the inhibition of NNMT.

5-Amino-1MQ and Cellular Energy Research

Cellular energy regulation is one of the main areas of 5-Amino-1MQ research. NNMT is positioned near NAD⁺ salvage, methionine metabolism, and methylation-dependent gene regulation.

NAD⁺ is required for cellular redox reactions and also serves as a substrate for several signaling enzymes. SAM is used in DNA, RNA, protein, lipid, and small-molecule methylation. Because NNMT consumes both nicotinamide and SAM, changes in NNMT activity can influence metabolism beyond the production of 1-MNA alone.

• NAD⁺-related metabolism → studied because nicotinamide is a major NAD⁺ salvage precursor
• SAM-dependent methylation → relevant because NNMT consumes SAM during nicotinamide methylation
• Energy expenditure → evaluated in adipose-tissue and diet-induced obesity models
• Lipid metabolism → examined through lipid accumulation and liver-fat measurements
• Metabolic flexibility → explored through glucose, insulin, and nutrient-response models

5-Amino-1MQ and Adipose-Tissue Research

Adipose-tissue biology is a major category of 5-Amino-1MQ research. White adipose tissue is metabolically active and contributes to lipid storage, hormone signaling, inflammation, glucose regulation, and whole-body energy balance.

Preclinical studies have evaluated NNMT suppression and 5-Amino-1MQ in cultured adipocytes and diet-induced obesity models. Researchers have reported changes involving lipid accumulation, adipocyte size, fat mass, body-weight trajectory, cholesterol, and metabolic signaling.

These findings do not establish human weight-loss efficacy. They explain why NNMT inhibition is studied as a possible regulator of adipocyte metabolism and energy balance.

• Adipocyte differentiation → studied through cultured fat-cell models
• Lipogenesis → evaluated through cellular lipid-accumulation assays
• Adipocyte size → measured in diet-induced obesity studies
• Fat mass → tracked in preclinical body-composition research
• Energy expenditure → investigated as a possible downstream effect of NNMT suppression

5-Amino-1MQ and Glucose-Regulation Research

5-Amino-1MQ has also been studied in models involving glucose tolerance, insulin sensitivity, and obesity-associated metabolic dysfunction.

In animal research, NNMT inhibition has been evaluated through measurements such as fasting glucose, circulating insulin, glucose-tolerance testing, insulin-response testing, liver triglycerides, and metabolic-gene expression.

These findings remain preclinical. They do not establish 5-Amino-1MQ as a treatment for insulin resistance, diabetes, metabolic syndrome, or liver disease.

5-Amino-1MQ and Skeletal-Muscle Research

Skeletal-muscle research is another important area of NNMT-inhibitor investigation. Muscle regeneration depends partly on muscle stem cells that can activate, proliferate, differentiate, and fuse in response to injury or tissue demand.

Preclinical studies have investigated whether NNMT inhibition can influence myoblast differentiation and restore aspects of aged muscle stem-cell activity. Research involving 5-Amino-1MQ has reported changes in proliferation, differentiation, fusion, and regenerative behavior in cultured cells and aged animal models.

This evidence does not establish 5-Amino-1MQ as a muscle-building, performance-enhancing, injury-recovery, or anti-aging compound for humans.

Common 5-Amino-1MQ Research Applications

5-Amino-1MQ research is most commonly centered on NNMT activity, cellular metabolism, adipose biology, glucose regulation, methylation balance, and skeletal-muscle regeneration.

• NNMT enzyme research → inhibitor potency, selectivity, and catalytic activity
• Cellular metabolism research → nicotinamide, NAD⁺, SAM, SAH, and 1-MNA pathways
• Adipose-tissue research → adipocyte differentiation, lipogenesis, and lipid storage
• Metabolic research → glucose tolerance, insulin sensitivity, and liver-lipid models
• Muscle-regeneration research → myoblast differentiation and muscle stem-cell activity
• Pharmacokinetic research → exposure, tissue distribution, clearance, and bioavailability

5-Amino-1MQ Compared With Other Metabolic Research Compounds

5-Amino-1MQ is often grouped with compounds studied for metabolism, mitochondrial function, body composition, or cellular energy, but its mechanism is distinct.

• 5-Amino-1MQ → NNMT inhibition and nicotinamide-metabolism research
• NAD⁺ → cellular redox and NAD-dependent enzyme research
• MOTS-c → mitochondrial-derived peptide signaling and metabolic research
• SLU-PP-332 → estrogen-related receptor and oxidative-metabolism research
• Tesamorelin → GHRH and growth-hormone-axis research
• Retatrutide → GLP-1, GIP, and glucagon receptor research

5-Amino-1MQ Handling and Storage Considerations

5-Amino-1MQ should be handled as a small-molecule laboratory reagent. Researchers should verify the exact chemical form, batch documentation, certificate of analysis, safety data sheet, solvent compatibility, and supplier-specific storage instructions before use.

Dry research material should generally be protected from unnecessary heat, light, moisture, and contamination. Once dissolved, stability can depend on solvent, concentration, pH, temperature, light exposure, and the intended analytical method.

Product-specific documentation and validated laboratory stability data should take priority over generalized storage claims.

Research-Only Compliance: What 5-Amino-1MQ Content Should and Should Not Claim

Because 5-Amino-1MQ is commonly discussed in connection with fat mass, energy expenditure, insulin sensitivity, NAD⁺, and muscle regeneration, precise research-only language is essential.

• Compliant → 5-Amino-1MQ is studied as a small-molecule NNMT inhibitor.
• Compliant → 5-Amino-1MQ is evaluated in adipocyte and metabolic research models.
• Compliant → Preclinical studies investigate how NNMT inhibition affects nicotinamide metabolism.
• Avoid → 5-Amino-1MQ burns fat or causes weight loss.
• Avoid → 5-Amino-1MQ improves insulin sensitivity in humans.
• Avoid → 5-Amino-1MQ boosts NAD⁺, energy, or muscle growth.

Related Compounds Studied With 5-Amino-1MQ

• NAD⁺ → studied in cellular energy, redox, and NAD-dependent enzyme systems
• MOTS-c → studied in mitochondrial signaling and metabolic regulation
• SLU-PP-332 → studied in oxidative metabolism and ERR signaling
• Tesamorelin → studied in growth-hormone-axis research
• Retatrutide → studied in triple-receptor metabolic signaling
• GHK-Cu → studied in tissue-remodeling and regenerative signaling

Related Research Compounds

• 5-Amino-1MQ
• All Research Compounds
• Ready-to-Ship Research Compounds
• Research Kits
• Peptide Storage Guide
• Peptide Calculator
• Research Hub

5-Amino-1MQ FAQs

What is 5-Amino-1MQ?

5-Amino-1MQ is a synthetic small-molecule inhibitor of nicotinamide N-methyltransferase, or NNMT. It is studied in cellular metabolism, nicotinamide processing, methyl-donor balance, adipose biology, glucose regulation, and muscle-regeneration models.

Is 5-Amino-1MQ a peptide?

No. 5-Amino-1MQ is a quinolinium-based small molecule and does not contain an amino-acid sequence or peptide bonds.

What enzyme does 5-Amino-1MQ inhibit?

5-Amino-1MQ is studied as an inhibitor of NNMT. NNMT catalyzes the methylation of nicotinamide using SAM as the methyl donor.

Does 5-Amino-1MQ directly supply NAD⁺?

No. 5-Amino-1MQ is not NAD⁺ or an NAD⁺ precursor. It is studied for inhibiting NNMT, which may indirectly alter nicotinamide-related metabolism in experimental systems.

Has 5-Amino-1MQ been proven to cause weight loss in humans?

No. Published findings commonly discussed for body-composition and metabolic effects are primarily based on cultured-cell and animal research.

Is 5-Amino-1MQ for human use?

No. 5-Amino-1MQ products from Method Peptides are sold for laboratory research purposes only and are not for human consumption, veterinary use, medical use, or diagnostic use.

Can 5-Amino-1MQ be described as a fat burner?

No. A more accurate research description is that 5-Amino-1MQ is studied as an NNMT inhibitor in adipose-tissue and metabolic research models.

Selected Research References

• Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014.
• Neelakantan H, Vance V, Wetzel MD, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochemical Pharmacology. 2018.
• Neelakantan H, Brightwell CR, Graber TG, et al. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochemical Pharmacology. 2019.
• Dimet-Wiley AL, et al. Reduced calorie diet combined with NNMT inhibition induces significant fat loss and alters the adipose metabolome in obese mice. Scientific Reports. 2022.

For research purposes only. Not for human consumption. This content is for educational and laboratory research discussion only. Method Peptides products are not intended to diagnose, treat, cure, or prevent any disease and are not for human or veterinary use.